Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nicolette Jeanblanc (North Chicago, United States of America), Nicolette Jeanblanc, Scott Manetz, Rozanne (Yen-Wah) Lee, Meina Liang, Partha Choudhury, Reena Varkey, Ethan Grant, Melissa Parker, Katie Streicher, Lydia Greenlees, Maria Datwyler, Gerard Davis, Koustubh Ranade. A new investigational use only automated immunoassay for periostin. Eur Respir J 2015; 46: Suppl. 59, 3936

Member's Comments

No comment yet.

Related content which might interest you: A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Performance characteristics of an ECL immunoassay for the quantitation of serum periostin Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Performance evaluation of a novel point-of-care total IgE assay system in atopic patients Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Calv,NO and J’awNO in asthma. A multidimensional approach Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Clinical and pathophysiological features of asthma phenotypes Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 The first U-BIOPRED blood handprint of severe asthma Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 The first U-BIOPRED sputum handprint of severe asthma Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review Source: International Congress 2014 – Airway biomarkers Year: 2014 Redefining the asthma treatment paradigm using a locally administered dual PI3Kgd inhibitor Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control Source: International Congress 2014 – Airway biomarkers Year: 2014 Dialysis plus ultrafiltration significantly improves the detection of cytokines in induced sputum Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Blockade of TSLP pathway alters asthma biomarkers Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Urinary LTE4 may be associated with TH2-driven asthma: Initial data from the Pan-European U-BIOPRED IMI project Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Asthma phenotypes with rapid decline in lung function Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016